Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on October 5, 2026

44 minutes ago

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Indeterminate GlobeNewswire

an hour ago

Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold

Indeterminate GlobeNewswire

an hour ago

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

an hour ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

an hour ago

Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026

Indeterminate GlobeNewswire

an hour ago

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Indeterminate GlobeNewswire

an hour ago

Satellos Granted Composition of Matter Patent for Forazapadin

Indeterminate GlobeNewswire

an hour ago

Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

Indeterminate GlobeNewswire

an hour ago

Iridex Completes Relocation of Manufacturing Facility to San Jose, California

Indeterminate GlobeNewswire

an hour ago

Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine

Indeterminate GlobeNewswire

an hour ago

BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth

Indeterminate GlobeNewswire

an hour ago

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

Indeterminate GlobeNewswire

an hour ago

Harrow Closes Acquisition of TYRVAYA®

Indeterminate GlobeNewswire

an hour ago

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Indeterminate GlobeNewswire

an hour ago

New Pico Laser for Tattoo Removal Includes Installation, On-Site Training and a Two-Year Warranty That Covers Technician Travel

Indeterminate GlobeNewswire

an hour ago

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Indeterminate GlobeNewswire

an hour ago

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

2 hours ago

Your Postal Code Shouldn’t Determine Your COPD Care. In Canada, It Still Does.

Indeterminate GlobeNewswire

2 hours ago

Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate

Indeterminate GlobeNewswire

3 hours ago

Digbi Health Study of Nearly 16,000 Members Finds Precision Biology GI Care Delivers IBS Relief at Scale

Indeterminate GlobeNewswire